Course and treatment of perianal disease in children newly diagnosed with Crohn's disease

Inflammatory Bowel Diseases

Volumn 15, Issue 3, 2009, Pages 383-387

  Keljo, David J ^a   Markowitz, James ^b   Langton, Christine ^a   Lerer, Trudy ^c   Bousvaros, Athos ^d   Carvalho, Ryan ^e   Crandall, Wallace ^f   Evans, Jonathan ^g   Griffiths, Anne ^h   Kay, Marsha ⁱ   Kugathasan, Subra ^j   LeLeiko, Neil ^k   Mack, David ^l   Mamula, Petar ^m   Moyer, M Susan ⁿ   Oliva Hemker, Maria ^o   Otley, Anthony ^p   Pfefferkorn, Marian ^q   Rosh, Joel ^r   Hyams, Jeffrey S ^c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b North Shore Long Island Jewish Health System ^*  (United States)

^c Farmington   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e CHILDREN S MEDICAL CENTER   (United States)

^f NATIONWIDE CHILDREN S HOSPITAL   (United States)

^g NEMOURS CHILDREN S CLINIC   (United States)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j MEDICAL COLLEGE OF WISCONSIN   (United States)

^k HASBRO CHILDREN'S HOSPITAL   (United States)

^l CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^m CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

ⁿ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^o JOHNS HOPKINS HOSPITAL   (United States)

^p IWK HEALTH CENTRE   (Canada)

^q RILEY HOSPITAL FOR CHILDREN   (United States)

^r MORRISTOWN MEMORIAL HOSPITAL   (United States)

more..

Author keywords

Anus disease; Crohn's disease; Pediatric; Rectal fistula

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOMODULATING AGENT; INFLIXIMAB; MESALAZINE; PREDNISONE; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ANUS DISEASE; ANUS FISTULA; ARTICLE; BODY MASS; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; NUTRITIONAL STATUS; PERIANAL ABSCESS; PRIORITY JOURNAL; RECTUM SURGERY; TREATMENT DURATION; TREATMENT RESPONSE; ABDOMINAL SURGERY; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; MALE; METHODOLOGY; MULTICENTER STUDY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; ANUS DISEASES; CHILD; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 66149091590     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20767     Document Type: Article

References (19)

1. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003;143:525-531.
2. Markowitz J, Daum F, Aiges H, et al. Perianal disease in children and adolescents with Crohn's disease. Gastroenterology. 1984;86:829-833.
3. Griffiths AM. Specificities of inflammatory bowel disease in childhood. Baillieres Best Pract Res Clin Gastroenterol. 2004;18:509-523.
4. Markowitz J, Grancher K, Rosa J, et al. Highly destructive perianal disease in children with Crohn's disease. J Pediatr Gastroenterol Nutr. 1995;21:149-153.
5. Tolia V. Perianal Crohn's disease in children and adolescents. Am J Gastroenterol. 1996;91:922-926.
6. Schwartz DA, Loftus EV, Jr., Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology. 2002;122:875-880.
7. Dejaco C, Harrer M, Waldhoer T, et al. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther. 2003;18:1113-1120.
8. Brandt LJ, Bernstein LH, Boley SJ, et al. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology. 1982;83: 383-387.
9. Bernstein LH, Frank MS, Brandt LJ, et al. Healing of perineal Crohn's disease with metronidazole. Gastroenterology. 1980;79:599.
10. Solomon MJ, Mcleod RS, Connor BI, et al. Combination ciprofloxacin and metronidazole in severe perianal Crohn's disease. Can J Gastroenterol. 1993;7:571-573.
11. Present DH, Korelitz BI, Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med. 1980;302:981-987.
12. Korelitz BI, Present DH. Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Dig Dis Sci. 1985;30:58-64.
13. Jeshion WC, Larsen KL, Jawad AF, et al. Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in children. J Clin Gastroenterol. 2000;30:294-298.
14. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999;340:1398-1405.
15. de Ridder L, Escher JC, Bouquet J, et al. Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands. J Pediatr Gastroenterol Nutr. 2004;39:46-52.
16. Jones JH, Lennard-Jones JE. Corticosteroids and corticotrophin in the treatment of Crohn's disease. Gut. 1966;7:181-187.
17. Sparberg M, Kirsner JB. Long-term corticosteroid therapy for regional enteritis: an analysis of 58 courses in 54 patients. Am J Dig Dis. 1966;11:865-880.
18. Malchow H, Ewe K, Brandes JW, et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology. 1984;86:249-266.
19. Lichtenstein GR. Treatment of fistulizing Crohn's disease. Gastroenterology. 2000;119:1132-1147.